{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:42:38Z","timestamp":1787240558846,"version":"build-2736575974"},"reference-count":124,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T00:00:00Z","timestamp":1744761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T00:00:00Z","timestamp":1744761600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Neurol Neurosci Rep"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose of Review<\/jats:title>\n                    <jats:p>Development of safe targeted therapies for idiopathic intracranial hypertension requires a thorough understanding of recent evidence discovering the pathophysiology of the condition. The aim is to provide a review of studies that inform on the underpinning mechanisms that have been associated with idiopathic intracranial hypertension.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent Findings<\/jats:title>\n                    <jats:p>People living with active idiopathic intracranial hypertension and obesity have been found to have with insulin resistance, hyperleptinaemia, and adverse cardiovascular outcomes. Clinically their adipose tissue is predominantly located in the truncal region and on detailed laboratory analysis the cells are primed for weight gain. There is evidence of androgen excess, altered glucocorticoid regulation and changes in pro-inflammatory cytokines. There are distinct alterations in metabolic pathways found in serum, urine and cerebrospinal fluid, that resolve following disease remission. These findings are associated with raised intracranial pressure and are likely secondary to cerebrospinal fluid hypersecretion.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>Idiopathic intracranial hypertension has a profile of systemic metabolic changes, endocrine dysfunction and cardiovascular risk profile distinct from that associated with obesity alone. These systemic metabolic changes are likely to contribute to dysregulation of cerebrospinal fluid dynamics, primarily hypersecretion but with a possible additional effect of reduced clearance resulting in the core feature of raised intracranial pressure.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11910-025-01420-y","type":"journal-article","created":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T05:23:16Z","timestamp":1744780996000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Current Understanding of the Pathophysiology of Idiopathic Intracranial Hypertension"],"prefix":"10.1007","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5712-3800","authenticated-orcid":false,"given":"Michael","family":"Lowe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3390-9508","authenticated-orcid":false,"given":"Gabriele","family":"Berman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9576-1050","authenticated-orcid":false,"given":"Priya","family":"Sumithran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6314-4437","authenticated-orcid":false,"given":"Susan P.","family":"Mollan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,16]]},"reference":[{"key":"1420_CR1","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/s41582-023-00893-0","volume":"19","author":"A Yiangou","year":"2023","unstructured":"Yiangou A, Mollan SP, Sinclair AJ. Idiopathic intracranial hypertension: a step change in understanding the disease mechanisms. Nat Rev Neurol. 2023;19:769\u201385. https:\/\/doi.org\/10.1038\/s41582-023-00893-0.","journal-title":"Nat Rev Neurol"},{"key":"1420_CR2","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s11910-024-01347-w","volume":"24","author":"PS Subramanian","year":"2024","unstructured":"Subramanian PS. Novel approaches to the treatment of idiopathic intracranial hypertension. Curr Neurol Neurosci Rep. 2024;24:265\u201372. https:\/\/doi.org\/10.1007\/s11910-024-01347-w.","journal-title":"Curr Neurol Neurosci Rep"},{"key":"1420_CR3","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1001\/jamaneurol.2019.1812","volume":"76","author":"NJ Adderley","year":"2019","unstructured":"Adderley NJ, Subramanian A, Nirantharakumar K, Yiangou A, Gokhale KM, Mollan SP et al. Association between idiopathic intracranial hypertension and risk of cardiovascular diseases in women in the United Kingdom. JAMA Neurol. 2019;76:1088\u201398. https:\/\/doi.org\/10.1001\/jamaneurol.2019.1812.","journal-title":"JAMA Neurol"},{"key":"1420_CR4","doi-asserted-by":"publisher","first-page":"417","DOI":"10.3390\/life11050417","volume":"11","author":"SP Mollan","year":"2021","unstructured":"Mollan SP, Mytton J, Tsermoulas G, Sinclair AJ. Idiopathic intracranial hypertension: evaluation of admissions and emergency readmissions through the hospital episode statistic dataset between 2002\u20132020. Life. 2021;11:417. https:\/\/doi.org\/10.3390\/life11050417.","journal-title":"Life"},{"key":"1420_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-024-03140-y","author":"L Bonelli","year":"2024","unstructured":"Bonelli L, Menon V, Arnold AC, Mollan SP. Managing idiopathic intracranial hypertension in the eye clinic. Eye. 2024. https:\/\/doi.org\/10.1038\/s41433-024-03140-y.","journal-title":"Eye"},{"key":"1420_CR6","doi-asserted-by":"publisher","first-page":"e000527","DOI":"10.1136\/bmjno-2023-000527","volume":"5","author":"S Abbott","year":"2023","unstructured":"Abbott S, Denton A, Wong SH, Mollan SP, Bul KC. Weight management communications in idiopathic intracranial hypertension: challenges and recommendations from the patients\u2019 perspective. BMJ Neurol Open. 2023;5:e000527. https:\/\/doi.org\/10.1136\/bmjno-2023-000527.","journal-title":"BMJ Neurol Open"},{"key":"1420_CR7","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1080\/01658107.2022.2153874","volume":"47","author":"HS Lyons","year":"2023","unstructured":"Lyons HS, Mollan SLP, Liu GT, Bowman R, Thaller M, Sinclair AJ, et al. Different characteristics of pre-pubertal and post-pubertal idiopathic intracranial hypertension: a narrative review. Neuro-Ophthalmology. 2023;47:63\u201374. https:\/\/doi.org\/10.1080\/01658107.2022.2153874.","journal-title":"Neuro-Ophthalmology"},{"key":"1420_CR8","doi-asserted-by":"publisher","DOI":"10.1177\/15910199241270660","author":"KM Fargen","year":"2024","unstructured":"Fargen KM, Midtlien JP, Margraf CR, Hui FK. Idiopathic intracranial hypertension pathogenesis: the jugular hypothesis. Interv Neuroradiol. 2024. https:\/\/doi.org\/10.1177\/15910199241270660.","journal-title":"Interv Neuroradiol"},{"key":"1420_CR9","doi-asserted-by":"publisher","unstructured":"Thaller M, Homer V, Abbott S, Hazlehurst J, Mollan SP, Sinclair AJ. Does a healthy weight body mass index at onset of idiopathic intracranial hypertension change the outcomes? A United Kingdom prospective cohort study. Neuro-Ophthalmology. 2024;1\u201312. https:\/\/doi.org\/10.1080\/01658107.2024.2341775.","DOI":"10.1080\/01658107.2024.2341775"},{"key":"1420_CR10","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1080\/14737175.2024.2359420","volume":"24","author":"O Potter","year":"2024","unstructured":"Potter O, Menon V, Mollan SP. Risk factors and disease associations in people living with idiopathic intracranial hypertension. Expert Rev Neurother. 2024;24:681\u20139. https:\/\/doi.org\/10.1080\/14737175.2024.2359420.","journal-title":"Expert Rev Neurother"},{"key":"1420_CR11","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.ophtha.2009.06.030","volume":"117","author":"A Kesler","year":"2010","unstructured":"Kesler A, Kliper E, Shenkerman G, Stern N. Idiopathic intracranial hypertension is associated with lower body adiposity. Ophthalmology. 2010;117:169\u201374. https:\/\/doi.org\/10.1016\/j.ophtha.2009.06.030.","journal-title":"Ophthalmology"},{"key":"1420_CR12","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1080\/01658107.2017.1334218","volume":"42","author":"C Hornby","year":"2018","unstructured":"Hornby C, Botfield H, O\u2019Reilly MW, Westgate C, Mitchell J, Mollan SP, et al. Evaluating the fat distribution in idiopathic intracranial hypertension using dual-energy X-ray absorptiometry scanning. Neuro-Ophthalmology. 2018;42:99\u2013104. https:\/\/doi.org\/10.1080\/01658107.2017.1334218.","journal-title":"Neuro-Ophthalmology"},{"key":"1420_CR13","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/ijo.2009.286","volume":"34","author":"KN Manolopoulos","year":"2010","unstructured":"Manolopoulos KN, Karpe F, Frayn KN. Gluteofemoral body fat as a determinant of metabolic health. Int J Obes. 2010;34:949\u201359. https:\/\/doi.org\/10.1038\/ijo.2009.286.","journal-title":"Int J Obes"},{"key":"1420_CR14","doi-asserted-by":"publisher","first-page":"e145346","DOI":"10.1172\/jci.insight.145346","volume":"6","author":"CSJ Westgate","year":"2021","unstructured":"Westgate CSJ, Botfield HF, Alimajstorovic Z, Yiangou A, Walsh M, Smith G, et al. Systemic and adipocyte transcriptional and metabolic dysregulation in idiopathic intracranial hypertension. JCI Insight. 2021;6:e145346. https:\/\/doi.org\/10.1172\/jci.insight.145346.","journal-title":"JCI Insight"},{"key":"1420_CR15","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1210\/er.2008-0024","volume":"29","author":"MA Cornier","year":"2008","unstructured":"Cornier MA, Dabelea D, Hernandez TL, Lindstrom RC, Steig AJ, Stob NR, et al. The metabolic syndrome. Endocr Rev. 2008;29:777\u2013822. https:\/\/doi.org\/10.1210\/er.2008-0024.","journal-title":"Endocr Rev"},{"key":"1420_CR16","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1111\/1471-0528.17241","volume":"129","author":"M Thaller","year":"2022","unstructured":"Thaller M, Mytton J, Wakerley BR, Mollan SP, Sinclair AJ. Idiopathic intracranial hypertension: evaluation of births and fertility through the hospital episode statistics dataset. BJOG. 2022;129:2019\u201327. https:\/\/doi.org\/10.1111\/1471-0528.17241.","journal-title":"BJOG"},{"key":"1420_CR17","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1111\/j.1526-4610.2008.001329.x","volume":"49","author":"S Dhungana","year":"2009","unstructured":"Dhungana S, Sharrack B, Woodroofe N. Cytokines and chemokines in idiopathic intracranial hypertension. Headache. 2009;49:282\u20135. https:\/\/doi.org\/10.1111\/j.1526-4610.2008.001329.x.","journal-title":"Headache"},{"key":"1420_CR18","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1111\/j.1365-2265.2008.03401.x","volume":"70","author":"AJ Sinclair","year":"2009","unstructured":"Sinclair AJ, Ball AK, Curnow SJ, Tomlinson JW, Burdon MA, Walker EA, et al. Elevated cerebrospinal fluid (CSF) leptin in idiopathic intracranial hypertension (IIH): evidence for hypothalamic leptin resistance? Clin Endocrinol (Oxf). 2009;70:863\u20139. https:\/\/doi.org\/10.1111\/j.1365-2265.2008.03401.x.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1420_CR19","doi-asserted-by":"publisher","unstructured":"Abdelghaffar M, Hussein M, Abdelkareem SA, Elshebawy H. Sex hormones, CSF and serum leptin in patients with idiopathic intracranial hypertension. Egypt J Neurol Psychiatry Neurosurg. 2022;58. https:\/\/doi.org\/10.1186\/s41983-022-00473-x.","DOI":"10.1186\/s41983-022-00473-x"},{"key":"1420_CR20","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1097\/WNO.0000000000000684","volume":"38","author":"C Hornby","year":"2018","unstructured":"Hornby C, Mollan SP, Botfield H, O\u2019Reilly MW, Sinclair AJ. Metabolic concepts in idiopathic intracranial hypertension and their potential for therapeutic intervention. J Neuroophthalmol. 2018;38:522\u201330. https:\/\/doi.org\/10.1097\/WNO.0000000000000684.","journal-title":"J Neuroophthalmol"},{"key":"1420_CR21","doi-asserted-by":"publisher","first-page":"E1702","DOI":"10.1212\/WNL.0000000000201007","volume":"99","author":"O Grech","year":"2022","unstructured":"Grech O, Seneviratne SY, Alimajstorovic Z, Yiangou A, Mitchell JL, Smith TB, et al. Nuclear magnetic resonance spectroscopy metabolomics in idiopathic intracranial hypertension to identify markers of disease and headache. Neurology. 2022;99:E1702\u201314. https:\/\/doi.org\/10.1212\/WNL.0000000000201007.","journal-title":"Neurology"},{"key":"1420_CR22","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1001\/jamaneurol.2021.0659","volume":"78","author":"SP Mollan","year":"2021","unstructured":"Mollan SP, Mitchell JL, Ottridge RS, Aguiar M, Yiangou A, Alimajstorovic Z, et al. Effectiveness of bariatric surgery vs community weight management intervention for the treatment of idiopathic intracranial hypertension: a randomized clinical trial. JAMA Neurol. 2021;78:678\u201386. https:\/\/doi.org\/10.1001\/jamaneurol.2021.0659.","journal-title":"JAMA Neurol"},{"key":"1420_CR23","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1021\/acs.jproteome.2c00449","volume":"22","author":"Z Alimajstorovic","year":"2023","unstructured":"Alimajstorovic Z, Mollan SP, Grech O, Mitchell JL, Yiangou A, Thaller M, et al. Dysregulation of amino acid, lipid, and acylpyruvate metabolism in idiopathic intracranial hypertension: a non-targeted case control and longitudinal metabolomic study. J Proteome Res. 2023;22:1127\u201337. https:\/\/doi.org\/10.1021\/acs.jproteome.2c00449.","journal-title":"J Proteome Res"},{"key":"1420_CR24","doi-asserted-by":"publisher","unstructured":"Alimajstorovic Z, Mitchell JL, Yiangou A, Hancox T, Southam AD, Grech O et al. Determining the role of novel metabolic pathways in driving intracranial pressure reduction after weight loss. Brain Commun 2023;5. https:\/\/doi.org\/10.1093\/braincomms\/fcad272.","DOI":"10.1093\/braincomms\/fcad272"},{"key":"1420_CR25","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1093\/brain\/awad003","volume":"146","author":"JL Mitchell","year":"2023","unstructured":"Mitchell JL, Lyons HS, Walker JK, Yiangou A, Grech O, Alimajstorovic Z, et al. The effect of GLP-1RA exenatide on idiopathic intracranial hypertension: a randomized clinical trial. Brain. 2023;146:1821\u201330. https:\/\/doi.org\/10.1093\/brain\/awad003.","journal-title":"Brain"},{"key":"1420_CR26","doi-asserted-by":"publisher","first-page":"2548","DOI":"10.1210\/jc.2004-0395","volume":"89","author":"EE Kershaw","year":"2004","unstructured":"Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab. 2004;89:2548\u201356. https:\/\/doi.org\/10.1210\/jc.2004-0395.","journal-title":"J Clin Endocrinol Metab"},{"key":"1420_CR27","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.steroids.2015.03.016","volume":"103","author":"J Li","year":"2015","unstructured":"Li J, Papadopoulos V, Vihma V. Steroid biosynthesis in adipose tissue. Steroids. 2015;103:89\u2013104. https:\/\/doi.org\/10.1016\/j.steroids.2015.03.016.","journal-title":"Steroids"},{"key":"1420_CR28","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.jsbmb.2014.04.008","volume":"143","author":"MW O\u2019Reilly","year":"2014","unstructured":"O\u2019Reilly MW, House PJ, Tomlinson JW. Understanding androgen action in adipose tissue. J Steroid Biochem Mol Biol. 2014;143:277\u201384. https:\/\/doi.org\/10.1016\/j.jsbmb.2014.04.008.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"1420_CR29","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1677\/joe.1.05762","volume":"183","author":"M Quinkler","year":"2004","unstructured":"Quinkler M, Sinha B, Tomlinson JW, Bujalska IJ, Stewart PM, Arlt W. Androgen generation in adipose tissue in women with simple obesity - a site-specific role for 17\u03b2-hydroxysteroid dehydrogenase type 5. J Endocrinol. 2004;183:331\u201342. https:\/\/doi.org\/10.1677\/joe.1.05762.","journal-title":"J Endocrinol"},{"key":"1420_CR30","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1530\/JOE-18-0674","volume":"241","author":"SA Amer","year":"2019","unstructured":"Amer SA, Alzanati NG, Warren A, Tarbox R, Khan R. Excess androgen production in subcutaneous adipose tissue of women with polycystic ovarian syndrome is not related to insulin or LH. J Endocrinol. 2019;241:99\u2013109. https:\/\/doi.org\/10.1530\/JOE-18-0674.","journal-title":"J Endocrinol"},{"key":"1420_CR31","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1186\/s12967-023-04116-4","volume":"21","author":"S Shabbir","year":"2023","unstructured":"Shabbir S, Khurram E, Moorthi VS, Eissa YTH, Kamal MA, Butler AE. The interplay between androgens and adipocytes: the foundation of comorbidities of polycystic ovary syndrome. J Transl Med. 2023;21:259. https:\/\/doi.org\/10.1186\/s12967-023-04116-4.","journal-title":"J Transl Med"},{"key":"1420_CR32","doi-asserted-by":"publisher","first-page":"972","DOI":"10.3109\/02713683.2013.799214","volume":"38","author":"A Klein","year":"2013","unstructured":"Klein A, Stern N, Osher E, Kliper E, Kesler A. Hyperandrogenism is associated with earlier age of onset of idiopathic intracranial hypertension in women. Curr Eye Res. 2013;38:972\u20136. https:\/\/doi.org\/10.3109\/02713683.2013.799214.","journal-title":"Curr Eye Res"},{"key":"1420_CR33","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.lab.2004.09.011","volume":"145","author":"CJ Glueck","year":"2005","unstructured":"Glueck CJ, Aregawi D, Goldenberg N, Golnik KC, Sieve L, Wang P. Idiopathic intracranial hypertension, polycystic-ovary syndrome, and thrombophilia. J Lab Clin Med. 2005;145:72\u201382. https:\/\/doi.org\/10.1016\/j.lab.2004.09.011.","journal-title":"J Lab Clin Med"},{"key":"1420_CR34","doi-asserted-by":"publisher","first-page":"3621","DOI":"10.1038\/s41433-023-02569-x","volume":"37","author":"M Thaller","year":"2023","unstructured":"Thaller M, Homer V, Sassani M, Mollan SP, Sinclair AJ. Longitudinal prospective cohort study evaluating prognosis in idiopathic intracranial hypertension patients with and without comorbid polycystic ovarian syndrome. Eye. 2023;37:3621\u20138. https:\/\/doi.org\/10.1038\/s41433-023-02569-x.","journal-title":"Eye"},{"key":"1420_CR35","doi-asserted-by":"publisher","unstructured":"O\u2019Reilly MW, Westgate CSJ, Hornby C, Botfield H, Taylor AE, Markey K et al. A unique androgen excess signature in idiopathic intracranial hypertension is linked to cerebrospinal fluid dynamics. JCI Insight 2019;4. https:\/\/doi.org\/10.1172\/jci.insight.125348.","DOI":"10.1172\/jci.insight.125348"},{"key":"1420_CR36","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/joim.13741","volume":"295","author":"J Seckl","year":"2024","unstructured":"Seckl J. 11\u03b2-Hydroxysteroid dehydrogenase and the brain: not (yet) lost in translation. J Intern Med. 2024;295:20\u201337. https:\/\/doi.org\/10.1111\/joim.13741.","journal-title":"J Intern Med"},{"key":"1420_CR37","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1210\/er.2012-1050","volume":"34","author":"LL Gathercole","year":"2013","unstructured":"Gathercole LL, Lavery GG, Morgan SA, Cooper MS, Sinclair AJ, Tomlinson JW, et al. 11\u03b2-Hydroxysteroid dehydrogenase 1: translational and therapeutic aspects. Endocr Rev. 2013;34:525\u201355. https:\/\/doi.org\/10.1210\/er.2012-1050.","journal-title":"Endocr Rev"},{"key":"1420_CR38","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1007\/s00125-014-3228-6","volume":"57","author":"A Stomby","year":"2014","unstructured":"Stomby A, Andrew R, Walker BR, Olsson T. Tissue-specific dysregulation of cortisol regeneration by 11\u03b2HSD1 in obesity: has it promised too much? Diabetologia. 2014;57:1100\u201310. https:\/\/doi.org\/10.1007\/s00125-014-3228-6.","journal-title":"Diabetologia"},{"key":"1420_CR39","doi-asserted-by":"publisher","first-page":"3330","DOI":"10.1210\/jcem.87.7.8661","volume":"87","author":"E Rask","year":"2002","unstructured":"Rask E, Walker BR, S\u00f6derberg S, Livingstone DE, Eliasson M, Johnson O, et al. Tissue-specific changes in peripheral cortisol metabolism in obese women: increased adipose 11-hydroxysteroid dehydrogenase type 1 activity. J Clin Endocrinol Metab. 2002;87:3330\u20136. https:\/\/doi.org\/10.1210\/jcem.87.7.8661.","journal-title":"J Clin Endocrinol Metab"},{"key":"1420_CR40","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1530\/EJE-22-0108","volume":"187","author":"CSJ Westgate","year":"2022","unstructured":"Westgate CSJ, Markey K, Mitchell JL, Yiangou A, Singhal R, Stewart P, et al. Increased systemic and adipose 11\u03b2-HSD1 activity in idiopathic intracranial hypertension. Eur J Endocrinol. 2022;187:323\u201333. https:\/\/doi.org\/10.1530\/EJE-22-0108.","journal-title":"Eur J Endocrinol"},{"key":"1420_CR41","doi-asserted-by":"publisher","first-page":"5348","DOI":"10.1210\/jc.2010-0729","volume":"95","author":"AJ Sinclair","year":"2010","unstructured":"Sinclair AJ, Walker EA, Burdon MA, Van Beek AP, Kema IP, Hughes BA, et al. Cerebrospinal fluid corticosteroid levels and cortisol metabolism in patients with idiopathic intracranial hypertension: a link between 11\u03b2-HSD1 and intracranial pressure regulation? J Clin Endocrinol Metab. 2010;95:5348\u201356. https:\/\/doi.org\/10.1210\/jc.2010-0729.","journal-title":"J Clin Endocrinol Metab"},{"key":"1420_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s42255-024-01079-8","author":"O Le Thuc","year":"2024","unstructured":"Le Thuc O, Garc\u00eda-C\u00e1ceres C. Obesity-induced inflammation: connecting the periphery to the brain. Nat Metab. 2024. https:\/\/doi.org\/10.1038\/s42255-024-01079-8.","journal-title":"Nat Metab"},{"key":"1420_CR43","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.jneuroim.2008.06.029","volume":"201\u2013202","author":"AJ Sinclair","year":"2008","unstructured":"Sinclair AJ, Ball AK, Burdon MA, Clarke CE, Stewart PM, Curnow SJ, et al. Exploring the pathogenesis of IIH: an inflammatory perspective. J Neuroimmunol. 2008;201\u2013202:212\u201320. https:\/\/doi.org\/10.1016\/j.jneuroim.2008.06.029.","journal-title":"J Neuroimmunol"},{"key":"1420_CR44","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1177\/0333102416650705","volume":"37","author":"B Samancl","year":"2017","unstructured":"Samancl B, Samancl Y, T\u00fcz\u00fcn E, Altlokka-Uzun G, Ekizoglu E, I\u00e7\u00f6z S, et al. Evidence for potential involvement of pro-inflammatory adipokines in the pathogenesis of idiopathic intracranial hypertension. Cephalalgia. 2017;37:525\u201331. https:\/\/doi.org\/10.1177\/0333102416650705.","journal-title":"Cephalalgia"},{"key":"1420_CR45","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1111\/ane.13482","volume":"144","author":"EM Fahmy","year":"2021","unstructured":"Fahmy EM, Rashed LA, Mostafa RH, Ismail RS. Role of tumor necrosis factor-alpha in the pathophysiology of idiopathic intracranial hypertension. Acta Neurol Scand. 2021;144:509\u201316. https:\/\/doi.org\/10.1111\/ane.13482.","journal-title":"Acta Neurol Scand"},{"key":"1420_CR46","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1177\/0333102415570762","volume":"35","author":"G Altlokka-Uzun","year":"2015","unstructured":"Altlokka-Uzun G, T\u00fcz\u00fcn E, Ekizo\u0287lu E, Ulusoy C, Yent\u00fcr S, K\u00fcrt\u00fcnc\u00fc M, et al. Oligoclonal bands and increased cytokine levels in idiopathic intracranial hypertension. Cephalalgia. 2015;35:1153\u201361. https:\/\/doi.org\/10.1177\/0333102415570762.","journal-title":"Cephalalgia"},{"key":"1420_CR47","doi-asserted-by":"publisher","unstructured":"El-Tamawy MS, Zaki MA, Rashed LA, Esmail EH, Mohamed SS, Osama W. Oligoclonal bands and levels of interleukin 4, interleukin 10, and tumor necrosis factor alpha in idiopathic intracranial hypertension Egyptian patients. Egypt J Neurol Psychiatry Neurosurg. 2019;55. https:\/\/doi.org\/10.1186\/s41983-019-0134-3.","DOI":"10.1186\/s41983-019-0134-3"},{"key":"1420_CR48","doi-asserted-by":"publisher","unstructured":"Hamed Reihani-Kermani, Mohsen Soltani Gerd, Mehdi Ansari, Alireza Ghafarinejad. Cerebrospinal fluid concentration of Interleukin-6 and Interleukin-10 in idiopathic intracranial hypertension. J Med Sci. 2008;8:205\u20138. https:\/\/doi.org\/10.3923\/jms.2008.205.208.","DOI":"10.3923\/jms.2008.205.208"},{"key":"1420_CR49","first-page":"234","volume":"2","author":"LJ Edwards","year":"2013","unstructured":"Edwards LJ, Sharrack B, Ismail A, Tench CR, Gran B, Dhungana S, et al. Increased levels of interleukins 2 and 17 in the cerebrospinal fluid of patients with idiopathic intracranial hypertension. Am J Clin Exp Immunol. 2013;2:234\u201344.","journal-title":"Am J Clin Exp Immunol"},{"key":"1420_CR50","doi-asserted-by":"publisher","unstructured":"Canac N, Jalaleddini K, Thorpe SG, Thibeault CM, Hamilton RB. Review: pathophysiology of intracranial hypertension and noninvasive intracranial pressure monitoring. Fluids Barriers CNS 2020;17. https:\/\/doi.org\/10.1186\/s12987-020-00201-8.","DOI":"10.1186\/s12987-020-00201-8"},{"key":"1420_CR51","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/nrn3921","volume":"16","author":"MP Lun","year":"2015","unstructured":"Lun MP, Monuki ES, Lehtinen MK. Development and functions of the choroid plexus-cerebrospinal fluid system. Nat Rev Neurosci. 2015;16:445\u201357. https:\/\/doi.org\/10.1038\/nrn3921.","journal-title":"Nat Rev Neurosci"},{"key":"1420_CR52","doi-asserted-by":"publisher","unstructured":"Johanson CE, Duncan JA, Klinge PM, Brinker T, Stopa EG, Silverberg GD. Multiplicity of cerebrospinal fluid functions: new challenges in health and disease. Cerebrospinal Fluid Res 2008;5. https:\/\/doi.org\/10.1186\/1743-8454-5-10.","DOI":"10.1186\/1743-8454-5-10"},{"key":"1420_CR53","doi-asserted-by":"publisher","unstructured":"MacAulay N, Keep RF, Zeuthen T. Cerebrospinal fluid production by the choroid plexus: a century of barrier research revisited. Fluids Barriers CNS 2022;19. https:\/\/doi.org\/10.1186\/s12987-022-00323-1.","DOI":"10.1186\/s12987-022-00323-1"},{"key":"1420_CR54","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/s41583-021-00454-8","volume":"22","author":"N MacAulay","year":"2021","unstructured":"MacAulay N. Molecular mechanisms of brain water transport. Nat Rev Neurosci. 2021;22:326\u201344. https:\/\/doi.org\/10.1038\/s41583-021-00454-8.","journal-title":"Nat Rev Neurosci"},{"key":"1420_CR55","doi-asserted-by":"publisher","DOI":"10.1002\/ca.24199","author":"L\u00d8 Johnsen","year":"2024","unstructured":"Johnsen L\u00d8, Friis KA, M\u00f8ller-Madsen MK, Damkier HH. Mechanisms of cerebrospinal fluid secretion by the choroid plexus epithelium: application to various intracranial pathologies. Clin Anat. 2024. https:\/\/doi.org\/10.1002\/ca.24199.","journal-title":"Clin Anat"},{"key":"1420_CR56","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1096\/fj.04-1711fje","volume":"19","author":"K Oshio","year":"2005","unstructured":"Oshio K, Watanabe H, Song Y, Verkman AS, Manley GT. Reduced cerebrospinal fluid production and intracranial pressure in mice lacking choroid plexus water channel Aquaporin-1. FASEB J. 2005;19:76\u20138. https:\/\/doi.org\/10.1096\/fj.04-1711fje.","journal-title":"FASEB J"},{"key":"1420_CR57","doi-asserted-by":"publisher","unstructured":"Steffensen AB, Oernbo EK, Stoica A, Gerkau NJ, Barbuskaite D, Tritsaris K et al. Cotransporter-mediated water transport underlying cerebrospinal fluid formation. Nat Commun 2018;9. https:\/\/doi.org\/10.1038\/s41467-018-04677-9.","DOI":"10.1038\/s41467-018-04677-9"},{"key":"1420_CR58","doi-asserted-by":"publisher","unstructured":"Oernbo EK, Steffensen AB, Razzaghi Khamesi P, Toft-Bertelsen TL, Barbuskaite D, Vilhardt F et al. Membrane transporters control cerebrospinal fluid formation independently of conventional osmosis to modulate intracranial pressure. Fluids Barriers CNS 2022;19. https:\/\/doi.org\/10.1186\/s12987-022-00358-4.","DOI":"10.1186\/s12987-022-00358-4"},{"key":"1420_CR59","doi-asserted-by":"publisher","unstructured":"Mondejar V, Patsalides A. The role of Arachnoid granulations and the glymphatic system in the pathophysiology of idiopathic intracranial hypertension. Curr Neurol Neurosci Rep 2020;20. https:\/\/doi.org\/10.1007\/s11910-020-01044-4.","DOI":"10.1007\/s11910-020-01044-4"},{"key":"1420_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-008-0457-0","volume":"117","author":"RO Weller","year":"2009","unstructured":"Weller RO, Djuanda E, Yow HY, Carare RO. Lymphatic drainage of the brain and the pathophysiology of neurological disease. Acta Neuropathol. 2009;117:1\u201314. https:\/\/doi.org\/10.1007\/s00401-008-0457-0.","journal-title":"Acta Neuropathol"},{"key":"1420_CR61","doi-asserted-by":"publisher","unstructured":"Ringstad G, Eide PK. Glymphatic-lymphatic coupling: assessment of the evidence from magnetic resonance imaging of humans. Cell Mol Life Sci. 2024;81. https:\/\/doi.org\/10.1007\/s00018-024-05141-2.","DOI":"10.1007\/s00018-024-05141-2"},{"key":"1420_CR62","doi-asserted-by":"publisher","unstructured":"Ringstad G, Valnes LM, Dale AM, Pripp AH, Vatnehol SAS, Emblem KE et al. Brain-wide glymphatic enhancement and clearance in humans assessed with MRI. JCI Insight 2018;3. https:\/\/doi.org\/10.1172\/jci.insight.121537.","DOI":"10.1172\/jci.insight.121537"},{"key":"1420_CR63","doi-asserted-by":"publisher","unstructured":"Iliff JJ, Wang M, Liao Y, Plogg BA, Peng W, Gundersen GA et al. A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid \u03b2. Sci Transl Med 2012;4. https:\/\/doi.org\/10.1126\/scitranslmed.3003748.","DOI":"10.1126\/scitranslmed.3003748"},{"key":"1420_CR64","doi-asserted-by":"publisher","unstructured":"Hladky SB, Barrand MA. The glymphatic hypothesis: the theory and the evidence. Fluids Barriers CNS 2022;19. https:\/\/doi.org\/10.1186\/s12987-021-00282-z.","DOI":"10.1186\/s12987-021-00282-z"},{"key":"1420_CR65","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1002\/ana.25928","volume":"89","author":"CH Wu","year":"2021","unstructured":"Wu CH, Lirng JF, Ling YH, Wang YF, Wu HM, Fuh JL, et al. Noninvasive characterization of human glymphatics and meningeal lymphatics in an in vivo model of blood-brain barrier leakage. Ann Neurol. 2021;89:111\u201324. https:\/\/doi.org\/10.1002\/ana.25928.","journal-title":"Ann Neurol"},{"key":"1420_CR66","doi-asserted-by":"publisher","unstructured":"Absinta M, Ha SK, Nair G, Sati P, Luciano NJ, Palisoc M et al. Human and nonhuman primate meninges harbor lymphatic vessels that can be visualized noninvasively by MRI. Elife 2017;6. https:\/\/doi.org\/10.7554\/eLife.29738.001.","DOI":"10.7554\/eLife.29738.001"},{"key":"1420_CR67","doi-asserted-by":"publisher","unstructured":"Eide PK, Vatnehol SAS, Emblem KE, Ringstad G. Magnetic resonance imaging provides evidence of glymphatic drainage from human brain to cervical lymph nodes. Sci Rep 2018;8. https:\/\/doi.org\/10.1038\/s41598-018-25666-4.","DOI":"10.1038\/s41598-018-25666-4"},{"key":"1420_CR68","first-page":"3475","volume":"19","author":"R Akay","year":"2015","unstructured":"Akay R, Kamisli O, Kahraman A, Oner S, Tecellioglu M. Evaluation of aqueductal CSF flow dynamics with phase contrast cine MR imaging in idiopathic intracranial hypertension patients: preliminary results. Eur Rev Med Pharmacol Sci. 2015;19:3475\u20139.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"1420_CR69","doi-asserted-by":"publisher","unstructured":"Belal T, Al Tantawy AE, Sherif FM, Ramadan A. Evaluation of cerebrospinal fluid flow dynamic changes in patients with idiopathic intracranial hypertension using phase contrast cine MR imaging. Egypt J Neurol Psychiatry Neurosurg. 2020;56. https:\/\/doi.org\/10.1186\/s41983-020-00227-7.","DOI":"10.1186\/s41983-020-00227-7"},{"key":"1420_CR70","doi-asserted-by":"publisher","first-page":"113","DOI":"10.2147\/EB.S404642","volume":"15","author":"SP Mollan","year":"2023","unstructured":"Mollan SP, Momin SNA, Khatkar PS, Tsermoulas G, Grech O, Sinclair AJ. A Neuro-Ophthalmologist\u2019s guide to advances in intracranial pressure measurements. Eye Brain. 2023;15:113\u201324. https:\/\/doi.org\/10.2147\/EB.S404642.","journal-title":"Eye Brain"},{"key":"1420_CR71","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s12987-022-00384-2","volume":"19","author":"JL Mitchell","year":"2022","unstructured":"Mitchell JL, Buckham R, Lyons H, Walker JK, Yiangou A, Sassani M, et al. Evaluation of diurnal and postural intracranial pressure employing telemetric monitoring in idiopathic intracranial hypertension. Fluids Barriers CNS. 2022;19:85. https:\/\/doi.org\/10.1186\/s12987-022-00384-2.","journal-title":"Fluids Barriers CNS"},{"key":"1420_CR72","doi-asserted-by":"publisher","first-page":"3353","DOI":"10.1007\/s00701-021-04940-x\/Published","volume":"163","author":"AL Kaipainen","year":"2021","unstructured":"Kaipainen AL, Martoma E, Puustinen T, Tervonen J, Jyrkk\u00e4nen H-K, Paterno JJ, et al. Cerebrospinal fluid dynamics in idiopathic intracranial hypertension: a literature review and validation of contemporary findings. Acta Neurochir (Wien). 2021;163:3353\u201368. https:\/\/doi.org\/10.1007\/s00701-021-04940-x\/Published.","journal-title":"Acta Neurochir (Wien)"},{"key":"1420_CR73","doi-asserted-by":"publisher","unstructured":"Okon MD, Roberts CJ, Mahmoud AM, Springer AN, Small RH, McGregor JM et al. Characteristics of the cerebrospinal fluid pressure waveform and craniospinal compliance in idiopathic intracranial hypertension subjects. Fluids Barriers CNS 2018;15. https:\/\/doi.org\/10.1186\/s12987-018-0106-5.","DOI":"10.1186\/s12987-018-0106-5"},{"key":"1420_CR74","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1007\/s00701-023-05572-z","volume":"165","author":"FT Afshari","year":"2023","unstructured":"Afshari FT, Samara M, Thant KZ, Byrne ME, Sinclair AJ, Mollan SP, et al. Interpretation of telemetric intracranial pressure recordings in people with idiopathic intracranial hypertension after shunt implantation. Acta Neurochir (Wien). 2023;165:1523\u201331. https:\/\/doi.org\/10.1007\/s00701-023-05572-z.","journal-title":"Acta Neurochir (Wien)"},{"key":"1420_CR75","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1038\/ijo.2017.83","volume":"41","author":"M Uldall","year":"2017","unstructured":"Uldall M, Bhatt DK, Kruuse C, Juhler M, Jansen-Olesen I, Jensen RH. Choroid plexus aquaporin 1 and intracranial pressure are increased in obese rats: towards an idiopathic intracranial hypertension model? Int J Obes. 2017;41:1141\u20137. https:\/\/doi.org\/10.1038\/ijo.2017.83.","journal-title":"Int J Obes"},{"key":"1420_CR76","doi-asserted-by":"publisher","unstructured":"Alimajstorovic Z, Pascual-Baixauli E, Hawkes CA, Sharrack B, Loughlin AJ, Romero IA et al. Cerebrospinal fluid dynamics modulation by diet and cytokines in rats. Fluids Barriers CNS 2020;17. https:\/\/doi.org\/10.1186\/s12987-020-0168-z.","DOI":"10.1186\/s12987-020-0168-z"},{"key":"1420_CR77","doi-asserted-by":"publisher","unstructured":"Wardman JH, Jensen MN, Andreassen SN, Styrishave B, Wilhjelm JE, Sinclair AJ et al. Modelling idiopathic intracranial hypertension in rats: contributions of high fat diet and testosterone to intracranial pressure and cerebrospinal fluid production. Fluids Barriers CNS 2023;20. https:\/\/doi.org\/10.1186\/s12987-023-00436-1.","DOI":"10.1186\/s12987-023-00436-1"},{"key":"1420_CR78","doi-asserted-by":"publisher","unstructured":"Eftekhari S, Westgate CSJ, Uldall MS, Jensen RH. Preclinical update on regulation of intracranial pressure in relation to idiopathic intracranial hypertension. Fluids Barriers CNS 2019;16. https:\/\/doi.org\/10.1186\/s12987-019-0155-4.","DOI":"10.1186\/s12987-019-0155-4"},{"key":"1420_CR79","doi-asserted-by":"publisher","unstructured":"Westgate CSJ, Hagen SM, Israelsen IME, Hamann S, Jensen RH, Eftekhari S. The impact of obesity-related raised intracranial pressure in rodents. Sci Rep 2022;12. https:\/\/doi.org\/10.1038\/s41598-022-13181-6.","DOI":"10.1038\/s41598-022-13181-6"},{"key":"1420_CR80","doi-asserted-by":"publisher","unstructured":"Israelsen IME, Kamp-Jensen C, Westgate CSJ, Styrishave B, Jensen RH, Eftekhari S. Cycle-dependent sex differences in expression of membrane proteins involved in cerebrospinal fluid secretion at rat choroid plexus. BMC Neurosci 2023;24. https:\/\/doi.org\/10.1186\/s12868-023-00829-w.","DOI":"10.1186\/s12868-023-00829-w"},{"key":"1420_CR81","doi-asserted-by":"publisher","unstructured":"Wardman JH, Andreassen SN, Toft-Bertelsen TL, Jensen MN, Wilhjelm JE, Styrishave B et al. CSF hyperdynamics in rats mimicking the obesity and androgen excess characteristic of patients with idiopathic intracranial hypertension. Fluids Barriers CNS 2024;21. https:\/\/doi.org\/10.1186\/s12987-024-00511-1.","DOI":"10.1186\/s12987-024-00511-1"},{"key":"1420_CR82","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1111\/j.1365-2826.2007.01569.x","volume":"19","author":"AJ Sinclair","year":"2007","unstructured":"Sinclair AJ, Onyimba CU, Khosla P, Vijapurapu N, Tomlinson JW, Burdon MA, et al. Corticosteroids, 11\u03b2-hydroxysteroid dehydrogenase isozymes and the rabbit choroid plexus. J Neuroendocrinol. 2007;19:614\u201320. https:\/\/doi.org\/10.1111\/j.1365-2826.2007.01569.x.","journal-title":"J Neuroendocrinol"},{"key":"1420_CR83","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1136\/jnnp.56.8.845","volume":"56","author":"JD Pickard","year":"1993","unstructured":"Pickard JD, Czosnyka M. Management of raised intracranial pressure. J Neurol Neurosurg Psychiatry. 1993;56:845\u201358. https:\/\/doi.org\/10.1136\/jnnp.56.8.845.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1420_CR84","doi-asserted-by":"publisher","unstructured":"Westgate CSJ, Israelsen IME, Kamp-Jensen C, Jensen RH, Eftekhari S. Glucocorticoids modify intracranial pressure in freely moving rats. Fluids Barriers CNS 2023;20. https:\/\/doi.org\/10.1186\/s12987-023-00439-y.","DOI":"10.1186\/s12987-023-00439-y"},{"key":"1420_CR85","doi-asserted-by":"publisher","unstructured":"Markey K, Mitchell J, Botfield H, Ottridge RS, Matthews T, Krishnan A, et al. 11\u03b2-Hydroxysteroid dehydrogenase type 1 inhibition in idiopathic intracranial hypertension: a double-blind randomized controlled trial. Brain Commun 2020;2. https:\/\/doi.org\/10.1093\/braincomms\/fcz050.","DOI":"10.1093\/braincomms\/fcz050"},{"key":"1420_CR86","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1210\/clinem\/dgaa766","volume":"106","author":"RS Hardy","year":"2021","unstructured":"Hardy RS, Botfield H, Markey K, Mitchell JL, Alimajstorovic Z, Westgate CSJ, et al. 11\u03b2HSD1 inhibition with AZD4017 improves lipid profiles and lean muscle mass in idiopathic intracranial hypertension. J Clin Endocrinol Metab. 2021;106:174\u201387. https:\/\/doi.org\/10.1210\/clinem\/dgaa766.","journal-title":"J Clin Endocrinol Metab"},{"key":"1420_CR87","doi-asserted-by":"publisher","unstructured":"Fargen KM, Coffman S, Torosian T, Brinjikji W, Nye BL, Hui F. \u201cIdiopathic\u201d intracranial hypertension: an update from neurointerventional research for clinicians. Cephalalgia 2023;43. https:\/\/doi.org\/10.1177\/03331024231161323.","DOI":"10.1177\/03331024231161323"},{"key":"1420_CR88","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1212\/wnl.49.2.507","volume":"49","author":"HJ Sugerman","year":"1997","unstructured":"Sugerman HJ, Demaria EJ, Felton WL, Nakatsuka M, Sismanis A. Increased intra-abdominal pressure and cardiac filling pressures in obesity-associated pseudotumor cerebri. Neurology. 1997;49:507\u201311. https:\/\/doi.org\/10.1212\/wnl.49.2.507.","journal-title":"Neurology"},{"key":"1420_CR89","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1136\/jnnp-2015-311302","volume":"87","author":"SP Mollan","year":"2016","unstructured":"Mollan SP, Ali F, Hassan-Smith G, Botfield H, Friedman DI, Sinclair AJ. Evolving evidence in adult idiopathic intracranial hypertension: pathophysiology and management. J Neurol Neurosurg Psychiatry. 2016;87:982\u201392. https:\/\/doi.org\/10.1136\/jnnp-2015-311302.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1420_CR90","doi-asserted-by":"publisher","unstructured":"Farb RI, Vanek I, Scott JN, Mikulis DJ, Willinsky RA, Tomlinson G et al. Idiopathic intracranial hypertension. The prevalence and morphology of sinovenous stenosis. Neurology 2003;60:1418\u201324. https:\/\/doi.org\/10.1212\/01.wnl.0000066683.34093.e2.","DOI":"10.1212\/01.wnl.0000066683.34093.e2"},{"key":"1420_CR91","doi-asserted-by":"publisher","unstructured":"Bsteh G, Marik W, Krajnc N, Macher S, Mitsch C, Pruckner P et al. MRI features of idiopathic intracranial hypertension are not prognostic of visual and headache outcome. J Headache Pain 2023;24. https:\/\/doi.org\/10.1186\/s10194-023-01641-x.","DOI":"10.1186\/s10194-023-01641-x"},{"key":"1420_CR92","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1111\/j.1552-6569.2012.00732.x","volume":"23","author":"A Horev","year":"2013","unstructured":"Horev A, Hallevy H, Plakht Y, Shorer Z, Wirguin I, Shelef I. Changes in cerebral venous sinuses diameter after lumbar puncture in idiopathic intracranial hypertension: a prospective MRI study. J Neuroimaging. 2013;23:375\u20138. https:\/\/doi.org\/10.1111\/j.1552-6569.2012.00732.x.","journal-title":"J Neuroimaging"},{"key":"1420_CR93","doi-asserted-by":"publisher","unstructured":"Buell T, Ding D, Raper D, Chen CJ, Aljuboori Z, Taylor D et al. Resolution of venous pressure gradient in a patient with idiopathic intracranial hypertension after ventriculoperitoneal shunt placement: a proof of secondary cerebral sinovenous stenosis. Surg Neurol Int 2021;12. https:\/\/doi.org\/10.25259\/SNI_700_2020.","DOI":"10.25259\/SNI_700_2020"},{"key":"1420_CR94","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1159\/000490578","volume":"7","author":"H Saber","year":"2018","unstructured":"Saber H, Lewis W, Sadeghi M, Rajah G, Narayanan S. Stent survival and stent-adjacent stenosis rates following venous sinus stenting for idiopathic intracranial hypertension: a systematic review and meta-analysis. Interv Neurol. 2018;7:490\u2013500. https:\/\/doi.org\/10.1159\/000490578.","journal-title":"Interv Neurol"},{"key":"1420_CR95","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1136\/neurintsurg-2019-015498","volume":"12","author":"KM Fargen","year":"2020","unstructured":"Fargen KM. Idiopathic intracranial hypertension is not idiopathic: proposal for a new nomenclature and patient classification. J Neurointerv Surg. 2020;12:110\u20134. https:\/\/doi.org\/10.1136\/neurintsurg-2019-015498.","journal-title":"J Neurointerv Surg"},{"key":"1420_CR96","doi-asserted-by":"publisher","unstructured":"Thaller M, Sinclair AJ, Tsermoulas G, Mollan SP. Considerations from venous stenosis to metabolic underpinnings in Idiopathic Intracranial Hypertension. Cephalalgia 2023;43. https:\/\/doi.org\/10.1177\/03331024231184445.","DOI":"10.1177\/03331024231184445"},{"key":"1420_CR97","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1212\/WNL.0000000000006166","volume":"91","author":"S Lenck","year":"2018","unstructured":"Lenck S, Radovanovic I, Nicholson P, Hodaie M, Krings T, Mendes-Pereira V. Idiopathic intracranial hypertension The veno glymphatic connections. Neurology. 2018;91:515\u201322. https:\/\/doi.org\/10.1212\/WNL.0000000000006166.","journal-title":"Neurology"},{"key":"1420_CR98","doi-asserted-by":"publisher","unstructured":"Eide PK, Pripp AH, Ringstad G, Valnes LM. Impaired glymphatic function in idiopathic intracranial hypertension. Brain Commun 2021;3:fcab043. https:\/\/doi.org\/10.1093\/braincomms\/fcab043.","DOI":"10.1093\/braincomms\/fcab043"},{"key":"1420_CR99","doi-asserted-by":"publisher","first-page":"149","DOI":"10.3174\/ajnr.A8088","volume":"45","author":"D Schartz","year":"2024","unstructured":"Schartz D, Finkelstein A, Hoang N, Bender MT, Schifitto G, Zhong J. Diffusion-weighted imaging reveals impaired glymphatic clearance in idiopathic intracranial hypertension. Am J Neuroradiol. 2024;45:149\u201354. https:\/\/doi.org\/10.3174\/ajnr.A8088.","journal-title":"Am J Neuroradiol"},{"key":"1420_CR100","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.brainres.2016.05.024","volume":"1644","author":"PK Eide","year":"2016","unstructured":"Eide PK, Eidsvaag VA, Nagelhus EA, Hansson HA. Cortical astrogliosis and increased perivascular aquaporin-4 in idiopathic intracranial hypertension. Brain Res. 2016;1644:161\u201375. https:\/\/doi.org\/10.1016\/j.brainres.2016.05.024.","journal-title":"Brain Res"},{"key":"1420_CR101","doi-asserted-by":"publisher","unstructured":"Eide PK, Hansson HA. A new perspective on the pathophysiology of idiopathic intracranial hypertension: role of the Glia-Neuro-Vascular interface. Front Mol Neurosci 2022;15. https:\/\/doi.org\/10.3389\/fnmol.2022.900057.","DOI":"10.3389\/fnmol.2022.900057"},{"key":"1420_CR102","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1002\/jnr.24743","volume":"99","author":"PK Eide","year":"2021","unstructured":"Eide PK, Hasan-Olive MM, Hansson HA, Enger R. Increased occurrence of pathological mitochondria in astrocytic perivascular endfoot processes and neurons of idiopathic intracranial hypertension. J Neurosci Res. 2021;99:467\u201380. https:\/\/doi.org\/10.1002\/jnr.24743.","journal-title":"J Neurosci Res"},{"key":"1420_CR103","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1093\/jnen\/nlz063","volume":"78","author":"MM Hasan-Olive","year":"2019","unstructured":"Hasan-Olive MM, Hansson HA, Enger R, Nagelhus EA, Eide PK. Blood-brain barrier dysfunction in idiopathic intracranial hypertension. J Neuropathol Exp Neurol. 2019;78:808\u201318. https:\/\/doi.org\/10.1093\/jnen\/nlz063.","journal-title":"J Neuropathol Exp Neurol"},{"key":"1420_CR104","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1097\/WNO.0000000000000736","volume":"39","author":"E Weinlander","year":"2019","unstructured":"Weinlander E, Derani T, Cornblath WT, De Lott LB. Intracranial hypertension in transgender patients. J Neuroophthalmol. 2019;39:232\u20133. https:\/\/doi.org\/10.1097\/WNO.0000000000000736.","journal-title":"J Neuroophthalmol"},{"key":"1420_CR105","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1097\/WNO.0b013e31815c431e","volume":"27","author":"C Sheets","year":"2007","unstructured":"Sheets C, Peden M, Guy J. Idiopathic intracranial hypertension in a transgender man. J Neuroophthalmol. 2007;27:313\u20135. https:\/\/doi.org\/10.1097\/WNO.0b013e31815c431e.","journal-title":"J Neuroophthalmol"},{"key":"1420_CR106","first-page":"1019","volume":"2","author":"I Buchanan","year":"2017","unstructured":"Buchanan I, Hansen K, Bedolla J. Idiopathic intracranial hypertension in a transgender male on hormone therapy. Arch Emerg Med Crit Care. 2017;2:1019.","journal-title":"Arch Emerg Med Crit Care"},{"key":"1420_CR107","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1097\/WNO.0000000000000926","volume":"41","author":"HV Nguyen","year":"2021","unstructured":"Nguyen HV, Gilbert AL, Fortin E, Vodopivec I, Torun N, Chwalisz BK, et al. Elevated intracranial pressure associated with exogenous hormonal therapy used for gender affirmation. J Neuroophthalmol. 2021;41:217\u201323. https:\/\/doi.org\/10.1097\/WNO.0000000000000926.","journal-title":"J Neuroophthalmol"},{"key":"1420_CR108","doi-asserted-by":"publisher","first-page":"156","DOI":"10.3109\/08820538.2013.788678","volume":"29","author":"S Park","year":"2014","unstructured":"Park S, Cheng CP, Lim LT, Gerber D. Secondary intracranial hypertension from testosterone therapy in a transgender patient. Semin Ophthalmol. 2014;29:156\u20138. https:\/\/doi.org\/10.3109\/08820538.2013.788678.","journal-title":"Semin Ophthalmol"},{"key":"1420_CR109","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1212\/CPJ.0000000000001172","volume":"12","author":"K Qureshi","year":"2022","unstructured":"Qureshi K, Qureshi S, Hassan A, Antonio A. Intracranial hypertension in a transgender man. Neurol Clin Pract. 2022;12:275\u20137. https:\/\/doi.org\/10.1212\/CPJ.0000000000001172.","journal-title":"Neurol Clin Pract"},{"key":"1420_CR110","doi-asserted-by":"publisher","first-page":"e151","DOI":"10.1097\/WNO.0000000000001458","volume":"43","author":"Y Mehta","year":"2023","unstructured":"Mehta Y, Seal LJ, Angus-Leppan H. Idiopathic intracranial hypertension in transgender people: case report and best practice. J Neuroophthalmol. 2023;43:e151\u20133. https:\/\/doi.org\/10.1097\/WNO.0000000000001458.","journal-title":"J Neuroophthalmol"},{"key":"1420_CR111","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1097\/IOP.0000000000002344","volume":"39","author":"NE Gutkind","year":"2023","unstructured":"Gutkind NE, Tse DT, Johnson TE, Tse BC. Idiopathic intracranial hypertension in female-to-male transgender patients on exogenous testosterone therapy. Ophthalmic Plast Reconstr Surg. 2023;39:449\u201353. https:\/\/doi.org\/10.1097\/IOP.0000000000002344.","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"1420_CR112","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1111\/j.1444-0938.2009.00404.x","volume":"92","author":"AD Mowl","year":"2009","unstructured":"Mowl AD, Grogg JA, Klein J. Secondary pseudotumour cerebri in a patient undergoing sexual reassignment therapy. Clin Exp Optom. 2009;92:449\u201353. https:\/\/doi.org\/10.1111\/j.1444-0938.2009.00404.x.","journal-title":"Clin Exp Optom"},{"key":"1420_CR113","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1080\/01658107.2017.1316744","volume":"41","author":"C Hornby","year":"2017","unstructured":"Hornby C, Mollan SP, Mitchell J, Markey KA, Yangou A, Wright BLC, et al. What do Transgender patients teach us about idiopathic intracranial hypertension? Neuro-Ophthalmology. 2017;41:326\u20139. https:\/\/doi.org\/10.1080\/01658107.2017.1316744.","journal-title":"Neuro-Ophthalmology"},{"key":"1420_CR114","doi-asserted-by":"publisher","unstructured":"Ronan GP, Sweeney B. Asymptomatic idiopathic intracranial hypertension post female to male gender transition. BMJ Case Rep 2021;14. https:\/\/doi.org\/10.1136\/bcr-2021-246454.","DOI":"10.1136\/bcr-2021-246454"},{"key":"1420_CR115","doi-asserted-by":"publisher","first-page":"e35","DOI":"10.1016\/j.jcjo.2018.04.021","volume":"54","author":"RR Sigireddi","year":"2019","unstructured":"Sigireddi RR, Lyons LJ, Lee AG. Idiopathic intracranial hypertension in a transgender female. Can J Ophthalmol. 2019;54:e35\u20138. https:\/\/doi.org\/10.1016\/j.jcjo.2018.04.021.","journal-title":"Can J Ophthalmol"},{"key":"1420_CR116","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1111\/ene.13739","volume":"25","author":"G McCluskey","year":"2018","unstructured":"McCluskey G, Doherty-Allan R, McCarron P, Loftus AM, McCarron LV, Mulholland D, et al. Meta-analysis and systematic review of population-based epidemiological studies in idiopathic intracranial hypertension. Eur J Neurol. 2018;25:1218\u201327. https:\/\/doi.org\/10.1111\/ene.13739.","journal-title":"Eur J Neurol"},{"key":"1420_CR117","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1212\/01.wnl.0000333254.84120.f5","volume":"72","author":"BB Bruce","year":"2009","unstructured":"Bruce BB, Kedar S, Van Stavern GP, Monaghan D, Acierno MD, Braswell RA, et al. Idiopathic intracranial hypertension in men. Neurology. 2009;72:304\u20139. https:\/\/doi.org\/10.1212\/01.wnl.0000333254.84120.f5.","journal-title":"Neurology"},{"key":"1420_CR118","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1097\/00041327-200103000-00004","volume":"21","author":"A Kesler","year":"2001","unstructured":"Kesler A, Goldhammer Y, Gadoth N. Do Men With Pseudotumor Cerebri Share the Same Characteristics as Women? A Retrospective Review of 141 Cases. J Neuroophthalmol. 2001;21:15\u20137. https:\/\/doi.org\/10.1097\/00041327-200103000-00004.","journal-title":"J Neuroophthalmol"},{"key":"1420_CR119","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1097\/WNO.0000000000001734","volume":"43","author":"A Kabanovski","year":"2023","unstructured":"Kabanovski A, Chan A, Shapiro C, Margolin E. Obstructive Sleep Apnea in Men With Idiopathic Intracranial Hypertension: a Prospective Case-Control Study. J Neuroophthalmol. 2023;43:531\u20134. https:\/\/doi.org\/10.1097\/WNO.0000000000001734.","journal-title":"J Neuroophthalmol"},{"key":"1420_CR120","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.jns.2009.11.001","volume":"290","author":"JA Fraser","year":"2010","unstructured":"Fraser JA, Bruce BB, Rucker J, Fraser LA, Atkins EJ, Newman NJ, et al. Risk factors for idiopathic intracranial hypertension in men: a case-control study. J Neurol Sci. 2010;290:86\u20139. https:\/\/doi.org\/10.1016\/j.jns.2009.11.001.","journal-title":"J Neurol Sci"},{"key":"1420_CR121","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.23660","author":"MA Abboud","year":"2022","unstructured":"Abboud MA, Nguyen TU, Smith JM, Campbell K. Hypogonadism and Intracranial Hypertension: a Case Report and Brief Review. Cureus. 2022. https:\/\/doi.org\/10.7759\/cureus.23660.","journal-title":"Cureus"},{"key":"1420_CR122","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1111\/iju.12273","volume":"21","author":"F Valcamonico","year":"2014","unstructured":"Valcamonico F, Arcangeli G, Consoli F, Nonnis D, Grisanti S, Gatti E, et al. Idiopathic intracranial hypertension: a possible complication in the natural history of advanced prostate cancer. Int J Urol. 2014;21:335\u20137. https:\/\/doi.org\/10.1111\/iju.12273.","journal-title":"Int J Urol"},{"key":"1420_CR123","doi-asserted-by":"publisher","first-page":"R125","DOI":"10.1530\/EJE-17-0124","volume":"177","author":"L Schiffer","year":"2017","unstructured":"Schiffer L, Kempegowda P, Arlt W, O\u2019Reilly MW. Mechanisms in endocrinology: the sexually dimorphic role of androgens in human metabolic disease. Eur J Endocrinol. 2017;177:R125\u201343. https:\/\/doi.org\/10.1530\/EJE-17-0124.","journal-title":"Eur J Endocrinol"},{"key":"1420_CR124","doi-asserted-by":"publisher","unstructured":"Abbott S, Chan F, Tahrani AA, Wong SH, Campbell FEJ, Parmar C et al. Weight management interventions for adults With idiopathic intracranial hypertension. Neurology 2023;101. https:\/\/doi.org\/10.1212\/WNL.0000000000207866.","DOI":"10.1212\/WNL.0000000000207866"}],"container-title":["Current Neurology and Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-025-01420-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11910-025-01420-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-025-01420-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T05:23:17Z","timestamp":1744780997000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11910-025-01420-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,16]]},"references-count":124,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1420"],"URL":"https:\/\/doi.org\/10.1007\/s11910-025-01420-y","relation":{},"ISSN":["1528-4042","1534-6293"],"issn-type":[{"value":"1528-4042","type":"print"},{"value":"1534-6293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,16]]},"assertion":[{"value":"5 April 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Additional Information"}}],"article-number":"31"}}